Latest UCLA's Jonsson Comprehensive Cancer Center Stories
The Vanderbilt-Ingram Cancer Center was accredited with the CEO Cancer Gold Standard(TM) certification, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.
U.S. researchers found aggressive, personalized treatment increases kidney cancer patient survival compared to the one-size-fits-all traditionally used.
By JEREMY COX PART 8BAD NEWS, AGAIN Diagnosed with cancer in her left breast in 1988 and then in her right in 2005, Cathy Holland beat both. When doctors told her that she had esophageal cancer in 2006 and throat cancer a year later, she beat those, too.
Today, the National Cancer Institute (NCI), the world's pre-eminent cancer research organization which leads the National Cancer Program and the U.S. effort to reduce the burden of cancer, was accredited with the CEO Cancer Gold Standard(TM) certification.
By Michelle Dynes Patients need to know where to get care and residents need to learn about prevention. By Michelle Dynes firstname.lastname@example.org CASPER - Cancer is the second leading cause of death in Wyoming.
PHILADELPHIA, Sept. 16 /PRNewswire/ -- A panel of leading breast cancer experts has identified and prioritized 12 late-stage, or Phase 3, breast cancer research studies, from a total of more than 515 currently underway, with the greatest potential to improve treatment and survival.
PHILADELPHIA and LONDON, Sept.
The finding comes out of a new study released by market intelligence firm Cutting Edge Information. According to Cutting Edge Information's research, total oncology sales will grow by 56% between 2007 and 2012. 2007 sales amounted to approximately $18 billion.
Pharmatech, a research management organization, has contracted with five pharmaceutical companies to provide research and site management services for their clinical trials using the just-in-time enrollment strategy.
Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life.
- To fire mitraille at.